The design, patient population and outcomes from the Bypass Angioplasty Revascularization Investigation (BARI)

M M Brooks1, K M Detre

  • 1The Epidemiology Data Center, University of Pittsburgh, PA 15261, USA.

Seminars in Interventional Cardiology : SIIC
|March 30, 2000
PubMed

Insights

Coronary artery bypass grafting (CABG) significantly improved 7-year survival in diabetic patients compared to percutaneous transluminal coronary angioplasty (PTCA). No survival difference was found between CABG and PTCA in non-diabetic patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Symptomatic multivessel coronary artery disease requires effective revascularization strategies.
  • Coronary artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA) are primary treatment options.
  • The Bypass Angioplasty Revascularization Investigation (BARI) aimed to compare these interventions.

Purpose of the Study:

  • To compare the long-term efficacy of CABG versus PTCA in patients with multivessel coronary artery disease.
  • To specifically evaluate treatment outcomes based on diabetic status.

Main Methods:

  • A randomized trial comparing CABG and PTCA.
  • Follow-up of 7-year survival and clinical events.
  • Subgroup analysis of patients with and without diabetes mellitus.

Main Results:

  • Overall 7-year survival favoured CABG.
  • In patients with diabetes mellitus, CABG showed an overwhelming survival benefit (23.6% vs 44.3% mortality, p=0.0011).
  • No significant difference in survival was observed for non-diabetic patients (13.6% vs 13.2%, p=0.72).
  • PTCA patients had fewer in-hospital Q-wave MIs but more repeat revascularizations and angina.

Conclusions:

  • CABG offers a significant survival advantage over PTCA for diabetic patients with multivessel coronary artery disease.
  • Treatment choice between CABG and PTCA should consider diabetic status.
  • Further research may explore mechanisms behind the differential treatment effect.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...